Kirke M. Hasson, Pillsbury’s Trials team head, handles complex intellectual property, contract and fiduciary duty cases. Kirke is an experienced litigator who prosecutes and defends a range of complex corporate cases, including disputes related to intellectual property, licensing and partnership agreements, and fiduciary duties for clients in the life sciences space.
His broad practice also encompasses defending challenges to mergers and acquisitions, advising clients involved in corporate and committee investigations, and litigating shareholder and securities actions.
He represents clients in federal and state courts, appellate proceedings and arbitration forums. For more than a decade, Kirke was the national co-leader of Pillsbury’s Litigation practice.
REPRESENTATIVE EXPERIENCE :
- Pursued action for Invitae Corporation to have declared invalid genetic testing patents asserted by Myriad Genetics in a multidistrict litigation in Utah. Following extensive litigation, Myriad abandoned its patent enforcement efforts.
- Represented selling stockholders of a drug development company regarding the collection of milestones related to regulatory progress of a drug.
- Campagnuolo v. IDEC Pharmaceuticals (U.S. District Court, S.D. Cal.) – Action challenging merger of IDEC Pharmaceuticals and Biogen
- Klein v. Salvi (S.D.N.Y.) – Defense of section 16(b) case relating to pharmaceutical company acquisition of biotech company in Eastern Europe
- Equity-Linked Investors v. Adams (Delaware Chancery Court) – Action challenging actions of directors of Genta regarding stock offering said to undervalue corporate assets regarding biotechnology company active in antisense field
- Represented former program head of major pharmaceutical company regarding federal investigation of alleged off-label promotion and violation of anti-kickback laws
- State of California ex rel. Richardson v. IREF et al. (Sicor) (California Superior Court) – Qui tam action challenging underpayments allegedly made to the University of California by a foundation and pharmaceutical developers
- Chiron v. SourceCF (U.S. District Court, N.D. Cal.) – Action alleging marketing of unsafe medical device for use in combination with drugs for treatment of CF
Associations : American Conservatory Theater, Chair of the Board of Trustees
- J.D., Harvard Law School, 1974
- B.A., Yale University, 1971
ADMISSIONS : California
Rate : $$$$